ATF5, a possible regulator of osteogenic differentiation in human adipose-derived stem cells.

Article Details

Citation

Leong DT, Abraham MC, Gupta A, Lim TC, Chew FT, Hutmacher DW

ATF5, a possible regulator of osteogenic differentiation in human adipose-derived stem cells.

J Cell Biochem. 2012 Aug;113(8):2744-53. doi: 10.1002/jcb.24150.

PubMed ID
22442021 [ View in PubMed
]
Abstract

The regulatory pathways involved in maintaining the pluripotency of embryonic stem cells are partially known, whereas the regulatory pathways governing adult stem cells and their "stem-ness" are characterized to an even lesser extent. We, therefore, screened the transcriptome profiles of 20 osteogenically induced adult human adipose-derived stem cell (ADSC) populations and investigated for putative transcription factors that could regulate the osteogenic differentiation of these ADSC. We studied a subgroup of donors' samples that had a disparate osteogenic response transcriptome from that of induced human fetal osteoblasts and the rest of the induced human ADSC samples. From our statistical analysis, we found activating transcription factor 5 (ATF5) to be significantly and consistently down-regulated in a randomized time-course study of osteogenically differentiated adipose-derived stem cells from human donor samples. Knockdown of ATF5 with siRNA showed an increased sensitivity to osteogenic induction. This evidence suggests a role for ATF5 in the regulation of osteogenic differentiation in adipose-derived stem cells. To our knowledge, this is the first report that indicates a novel role of transcription factors in regulating osteogenic differentiation in adult or tissue specific stem cells.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Cyclic AMP-dependent transcription factor ATF-5Q9Y2D1Details